Research Library

Peptides & Skin Biology

Peptides are short chains of amino acids involved in many biological processes, including cell communication, tissue structure and repair. In skin science, researchers are investigating how different peptides may interact with pathways involved in collagen production, extracellular matrix organisation, inflammation, pigmentation and the skin barrier.

The research is particularly relevant to women because skin biology changes throughout life. Ageing, hormonal fluctuations, pregnancy, menopause, environmental exposure and other biological factors can influence collagen, hydration, elasticity and barrier function.

Peptides in Skin Biology

Skin is a highly active biological organ made up of multiple cell types, structural proteins and signalling systems. Peptides can participate in these systems by acting as signalling molecules or by influencing cellular activity.

Research is examining how specific peptides interact with skin cells such as fibroblasts and keratinocytes. Fibroblasts are particularly important because they produce components of the extracellular matrix, including collagen and elastin.

Researchers are investigating peptides in areas including:

• Cellular signalling
• Collagen and extracellular matrix regulation
• Skin repair and regeneration
• Inflammatory pathways
• Oxidative stress
• Skin hydration and barrier function
• Pigmentation and melanocyte activity

The effects of peptides are highly dependent on their structure, concentration, delivery system and biological target. A peptide identified in laboratory research should not automatically be interpreted as a proven cosmetic or clinical treatment.

Collagen & Extracellular Matrix Research

The extracellular matrix (ECM) is the structural network surrounding skin cells. It contains proteins including collagen, elastin and glycosaminoglycans that contribute to the skin’s strength, elasticity and overall architecture.

Collagen is particularly important because it provides structural support within the dermis. As people age, changes in collagen production and breakdown contribute to alterations in skin firmness and elasticity.

Peptide research in this area includes investigation into whether certain peptides can influence fibroblast activity and collagen-related signalling pathways. Some peptides may also function as fragments or signals associated with the breakdown and rebuilding of extracellular matrix components.

Researchers are studying these mechanisms to better understand how peptide signalling could influence:

• Collagen synthesis
• Extracellular matrix organisation
• Fibroblast activity
• Skin elasticity and firmness
• Tissue remodelling

This research is important to skin science, but laboratory findings do not necessarily translate directly into measurable effects in humans. Human clinical evidence remains an important part of evaluating whether a peptide has meaningful benefits.

Copper Peptide Research

Copper peptides are complexes in which a peptide is associated with copper ions. One of the best-known examples is GHK-Cu, which has attracted interest in dermatological and cosmetic research.

Research has investigated copper peptides in relation to processes including extracellular matrix biology, collagen-related activity, wound repair and cellular signalling.

Laboratory and preclinical research suggests that copper-containing peptides can interact with biological pathways involved in tissue maintenance and repair. Researchers have therefore explored their potential relevance to skin ageing and regeneration.

Areas of investigation include:

• Collagen and extracellular matrix processes
• Fibroblast activity
• Tissue repair
• Inflammatory signalling
• Oxidative stress
• Skin structure and ageing

Copper peptide research remains an evolving field. Evidence varies depending on the specific peptide, formulation, delivery method and type of study, so research findings should be considered in context rather than treated as proof of a universal anti-ageing effect.

Peptide-Based Cosmetic Science

Peptides have become an important area of cosmetic research because their small molecular structures can interact with biological processes involved in skin appearance and function.

Cosmetic scientists are investigating different categories of peptides, including signal peptides, carrier peptides and peptides designed to influence specific cellular pathways.

In topical skincare, researchers are particularly interested in whether peptide formulations can reach relevant layers of the skin and remain sufficiently stable to have a biological effect.

Research and formulation science therefore consider factors such as:

• Peptide stability
• Molecular structure
• Skin penetration
• Concentration
• Delivery systems
• Formulation compatibility
• Interactions with other cosmetic ingredients

A product containing a peptide does not automatically have the same evidence behind it as the peptide itself. The final formulation, concentration and delivery system can substantially influence its performance.

Skin Barrier Research

The skin barrier is the body’s first line of defence against the external environment. The outermost layer of the epidermis, particularly the stratum corneum, helps regulate water loss while providing protection against environmental irritants and microorganisms.

Research into peptides and skin barrier biology is exploring how certain peptides may interact with keratinocytes, lipids, inflammatory pathways and other components involved in maintaining skin integrity.

Areas of investigation include:

• Barrier integrity
• Transepidermal water loss (TEWL)
• Skin hydration
• Keratinocyte function
• Inflammatory signalling
• Recovery following barrier disruption

A healthy skin barrier is particularly relevant when considering cosmetic and dermatological research because barrier disruption can contribute to dryness, sensitivity and increased reactivity.

Peptide research in this area is therefore focused not only on appearance, but also on understanding the biological mechanisms that help maintain resilient, functioning skin.

Peptides & Women’s Health Research

Female biology is influenced by complex interactions between hormones, metabolism, reproductive tissues, the nervous system and immune function. Peptides are involved in many of these processes, making them an important area of ongoing research.

Researchers are investigating how naturally occurring and synthetic peptides interact with biological pathways and whether studying these mechanisms can improve our understanding of women’s health.

Peptides & Reproductive Biology

Reproductive biology involves coordinated activity between the brain, ovaries, uterus and other reproductive tissues. Peptides contribute to communication within these systems and are being studied for their roles in reproductive physiology.

Research includes:

• Ovarian function and follicular development
• Ovulation and menstrual-cycle biology
• Fertility and reproductive physiology
• Uterine and reproductive tissue function
• Communication between the brain and reproductive organs

Understanding these mechanisms helps researchers build a clearer picture of how reproductive processes are regulated and how they change across a woman’s reproductive lifespan.

Hormonal Signalling

Hormones act as chemical messengers, influencing the activity of tissues throughout the body. Some hormones are peptides themselves, while others interact with peptide-mediated pathways.

Research in this area looks at how hormonal signals are produced, transported, recognised by receptors and translated into cellular responses.

Key areas include:

• Oestrogen and progesterone biology
• Hypothalamic and pituitary hormones
• Hormone-receptor interactions
• Cellular responses to hormonal changes
• Hormonal changes across the menstrual cycle
• Endocrine changes during pregnancy and menopause

Because hormone levels and sensitivity change throughout a woman’s life, understanding these mechanisms is an important part of female biology research.

Metabolic Research

Metabolism describes how the body manages energy, nutrients and fuel. Peptide hormones are involved in regulating appetite, glucose control, insulin secretion, energy expenditure and communication between organs.

Research has particularly focused on signalling between the gut, pancreas, brain and adipose tissue.

Areas of investigation include:

• Glucose regulation
• Insulin secretion
• Appetite and satiety
• Energy expenditure
• Fat metabolism
• Gut-brain communication
• Metabolic adaptation

Women’s metabolic physiology can also change across the reproductive lifespan, making sex-specific research increasingly relevant to understanding metabolic health.

Endocrine Signalling

The endocrine system is an interconnected network of glands and tissues that regulates functions throughout the body. Rather than operating as isolated pathways, endocrine systems use feedback loops to maintain physiological balance.

The hypothalamus and pituitary act as important regulatory centres, coordinating activity involving the thyroid, adrenal glands and reproductive organs.

Research in this field examines:

• Hypothalamic-pituitary regulation
• Thyroid function
• Adrenal physiology
• Reproductive endocrine function
• Hormonal feedback loops
• Interactions between endocrine systems

This broader systems-level perspective helps researchers understand how changes in one hormonal pathway can influence other aspects of physiology.

Emerging Women’s Health Research

Women’s health research is expanding into areas that have historically received less scientific attention. Researchers are increasingly investigating biological differences across the female lifespan and how these may influence health and disease.

Emerging areas of interest include:

• Menstrual-cycle biology
• Menopause and healthy ageing
• Ovarian biology
• Female metabolic physiology
• Reproductive health
• Neuroendocrine research
• Inflammation and immune biology
• Peptide-based approaches to women’s health

Some areas have substantial scientific evidence, while others remain at the laboratory or early clinical research stage. A promising biological mechanism does not necessarily mean that a peptide has been proven effective or safe for a particular use.

At Peps4Her, the aim is to make this evolving science easier to understand — distinguishing established evidence from early findings and putting emerging peptide research into the wider context of women’s biology.

Metabolic Science

Metabolism is the network of processes that allows the body to obtain, store and use energy. Peptides and peptide hormones play important roles in coordinating appetite, glucose regulation, insulin release, digestion and energy balance.

Metabolic peptide research has become a major area of biomedical science, with researchers studying how these signalling systems influence communication between the gut, pancreas, brain, liver, muscle and adipose tissue.

Peptide Hormones

Peptide hormones are signalling molecules made from chains of amino acids. They are released by tissues throughout the body and can influence processes such as appetite, glucose control, digestion and energy use.

Important metabolic peptide hormones include GLP-1, GIP, insulin, glucagon and several gut-derived peptides involved in appetite and nutrient regulation.

Research is examining how these hormones:

• Respond to food intake
• Influence pancreatic function
• Affect glucose levels
• Regulate appetite and satiety
• Communicate between metabolic organs
• Adapt to changes in energy availability

Understanding these hormones has helped researchers develop new approaches to metabolic disease and continues to reveal how closely appetite, digestion and energy regulation are connected.

Appetite & Metabolic Signalling

Appetite is regulated by communication between the gastrointestinal tract, brain and peripheral tissues. Rather than being controlled by a single pathway, hunger and satiety are influenced by multiple signals responding to food intake, nutrient availability and energy stores.

Gut-derived peptides can communicate with areas of the brain involved in appetite regulation. Signals from the digestive system can therefore influence whether the body promotes hunger, satiety or continued food intake.

Research is exploring:

• Hunger and satiety pathways
• Gut-brain communication
• Meal-related peptide release
• Central appetite regulation
• Nutrient sensing
• Long-term energy balance

These pathways are particularly important in understanding obesity and metabolic disease, where appetite regulation and energy balance can become disrupted.

GLP-Related Research

Glucagon-like peptide-1 (GLP-1) is a naturally occurring hormone produced primarily in the intestine after food intake. It is involved in several aspects of metabolic regulation.

GLP-1 research has examined its effects on:

• Glucose-dependent insulin secretion
• Glucagon regulation
• Gastric emptying
• Appetite and satiety
• Food intake
• Blood-glucose control

GLP-1 receptor agonists have subsequently become an important area of clinical medicine, particularly in the treatment of type 2 diabetes and obesity.

Research has also expanded beyond GLP-1 alone. Scientists are investigating combinations and interactions involving other metabolic pathways, including glucose-dependent insulinotropic polypeptide (GIP), glucagon and additional gut-derived signals.

This research is helping scientists understand why targeting multiple metabolic pathways may produce different physiological effects from targeting a single pathway.

Insulin Signalling

Insulin is a central regulator of glucose and nutrient metabolism. It is produced by pancreatic beta cells and released in response to changes in blood glucose and other metabolic signals.

When insulin binds to its receptor, it activates intracellular pathways that influence how tissues take up and store nutrients.

Research into insulin signalling examines processes including:

• Glucose uptake
• Glycogen synthesis
• Fat storage and metabolism
• Protein synthesis
• Cellular nutrient sensing
• Insulin resistance

Insulin resistance occurs when cells respond less effectively to insulin. It is a major feature of metabolic dysfunction and plays an important role in the development of type 2 diabetes.

Understanding insulin signalling at a cellular level remains an important area of metabolic research.

Energy Metabolism

Energy metabolism involves the processes through which the body converts nutrients into usable energy and determines how that energy is stored or utilised.

Multiple organs contribute to this process. The liver, skeletal muscle, adipose tissue, pancreas, gastrointestinal tract and brain continuously exchange metabolic signals to maintain energy balance.

Researchers are investigating how peptide pathways influence:

• Energy expenditure
• Nutrient utilisation
• Fat oxidation
• Glucose metabolism
• Mitochondrial activity
• Energy storage
• Adaptation to changes in energy availability

Metabolic research increasingly considers these processes as an interconnected system rather than isolated pathways.

For women, this field is particularly relevant because metabolic physiology can change across the reproductive lifespan, including during the menstrual cycle, pregnancy, postpartum period and menopause.

At Peps4Her, the focus is on explaining the underlying science: how metabolic peptides work, what researchers have discovered, and where evidence is still developing.

Cellular Science

Peptides can influence biology at the cellular level by interacting with receptors, signalling pathways and intracellular processes. Researchers study these mechanisms to understand how peptides may affect cellular communication, energy production, stress responses, inflammation and tissue maintenance.

Cellular peptide research spans many areas of biology, from mitochondrial function and oxidative stress to the processes involved in cellular repair and adaptation.

Mitochondrial Research

Mitochondria are specialised structures within cells responsible for producing much of the energy required for cellular activity. They also participate in processes including calcium regulation, cellular stress responses and programmed cell death.

Researchers are investigating whether certain peptides can influence mitochondrial function and the pathways that regulate cellular energy production.

Areas of interest include:

• ATP production
• Mitochondrial efficiency
• Cellular energy availability
• Mitochondrial membrane function
• Mitochondrial stress responses
• Communication between mitochondria and the rest of the cell

Mitochondrial research is particularly relevant to tissues with high energy demands, including muscle, brain and heart tissue.

Cellular Signalling

Cells constantly receive and transmit information. Peptides can participate in this communication by binding to receptors on the cell surface or, in some cases, interacting with intracellular targets.

Receptor activation can trigger signalling cascades that alter gene expression, enzyme activity, metabolism or cellular behaviour.

Researchers investigate pathways such as:

• G-protein-coupled receptor (GPCR) signalling
• Protein kinase pathways
• Second-messenger systems
• Calcium signalling
• Gene-regulatory pathways
• Cell-to-cell communication

Understanding these pathways is fundamental to peptide biology because the biological effect of a peptide depends not only on the peptide itself, but also on the receptor, cell type and signalling environment involved.

Oxidative Stress Research

Cells naturally produce reactive oxygen species (ROS) as part of normal metabolism. At controlled levels, these molecules can participate in cellular signalling. Excessive or poorly controlled oxidative stress, however, can damage proteins, lipids and DNA.

Researchers are studying whether certain peptides influence the cellular systems responsible for maintaining redox balance.

Research includes investigation of:

• Reactive oxygen species
• Antioxidant defence systems
• Mitochondrial oxidative stress
• Cellular damage responses
• Redox signalling
• Oxidative stress and ageing

Understanding these mechanisms may help researchers investigate how cells respond to environmental, metabolic and physiological stress.

Inflammation Pathways

Inflammation is a coordinated biological response involving immune cells, signalling molecules and changes in tissue activity. Peptides can interact with pathways involved in both the initiation and regulation of inflammatory responses.

Research examines how peptide biology may influence mediators such as cytokines, chemokines and other inflammatory signalling molecules.

Areas being investigated include:

• Cytokine signalling
• Immune-cell activation
• Inflammatory mediator release
• NF-κB-related pathways
• Cellular stress responses
• Resolution of inflammation

The relationship between peptides and inflammation is complex. Effects can vary considerably according to the specific peptide, tissue, dose and biological context.

Cellular Repair Research

Cells have sophisticated systems for detecting damage, repairing cellular components and maintaining tissue integrity. Peptide research is investigating whether certain peptides can influence these processes.

Scientists study mechanisms involved in:

• DNA and protein repair
• Cell migration
• Cell proliferation
• Tissue remodelling
• Extracellular matrix production
• Cellular survival
• Wound-healing processes

Some research examines how peptides interact with growth factors, receptors and signalling pathways involved in tissue repair. Other studies focus on how cells respond to injury or stress at a molecular level.

Much of this work remains preclinical, meaning findings may come from laboratory or animal models rather than human clinical trials. These studies can identify promising mechanisms, but further research is required to determine whether those mechanisms translate into meaningful outcomes in people.

Understanding the Cellular Evidence

Peptide biology is ultimately about mechanism: what a peptide interacts with, what pathway it activates or inhibits, and how that changes cellular behaviour.

Peps4Her separates these mechanistic findings from claims about human outcomes, helping readers understand where the science is established, where evidence is promising, and where research is still at an early stage.

Peptide Laboratory & Analytical Science

Understanding peptide research requires more than studying biological effects. Researchers also need to establish what a peptide actually contains, how pure it is, how it behaves under different conditions and whether its chemical characteristics remain consistent over time.

Analytical chemistry provides the tools used to characterise peptide materials, investigate impurities and degradation, and assess properties such as identity, purity and stability.

HPLC & Chromatographic Analysis

High-performance liquid chromatography (HPLC) is one of the most widely used analytical techniques in peptide science. It separates components within a sample based on differences in their chemical and physical properties.

In peptide analysis, HPLC can help researchers examine:

• Peptide purity
• Related peptide impurities
• Degradation products
• Synthesis by-products
• Changes in a sample over time
• Differences between batches

A chromatogram displays separated components as peaks. Researchers can use the resulting pattern to assess whether the expected peptide is present and whether additional components are detectable.

HPLC is therefore an important part of peptide characterisation, although a high purity result alone does not establish biological activity, safety or clinical effectiveness.

Mass Spectrometry

Mass spectrometry (MS) is an analytical technique used to determine the mass-to-charge ratio of ions. In peptide research, it can provide highly specific information about molecular identity and composition.

Researchers can use mass spectrometry to investigate:

• Molecular mass
• Peptide identity
• Sequence-related information
• Modification of peptide molecules
• Degradation products
• Impurities

Techniques such as liquid chromatography–mass spectrometry (LC-MS) combine chromatographic separation with mass analysis, allowing researchers to examine complex peptide samples in greater detail.

Mass spectrometry can therefore complement HPLC by providing information about what a separated component actually is, rather than simply showing that a component is present.

Peptide Synthesis

Peptides can be produced through biological systems or manufactured using chemical synthesis. One of the most widely used laboratory approaches is solid-phase peptide synthesis (SPPS).

In SPPS, amino acids are sequentially attached to a growing peptide chain while the chain remains linked to a solid support. Repeated cycles of coupling and deprotection allow researchers to build the desired sequence.

After synthesis, the peptide generally requires additional processing and characterisation.

Researchers may assess:

• Correct amino-acid sequence
• Reaction efficiency
• Side products
• Deletion sequences
• Purity
• Molecular mass
• Structural characteristics

The complexity of synthesis increases with peptide length and sequence, and some peptides require specialised chemistry or additional purification steps.

Lyophilisation

Lyophilisation, commonly known as freeze-drying, is a technique used to remove water from a material under controlled conditions.

The process generally involves freezing the material and then reducing the surrounding pressure so that frozen water can transition directly from solid to vapour.

For peptide materials, lyophilisation can be used to produce a dry preparation that may be more suitable for storage or subsequent analytical work.

Researchers consider factors such as:

• Moisture content
• Peptide stability
• Formulation composition
• Freezing conditions
• Drying conditions
• Reconstitution behaviour

Lyophilisation does not automatically make a peptide stable indefinitely. Stability depends on the individual peptide and the conditions under which it is stored.

Stability Testing

Peptides can undergo chemical and physical changes over time. Temperature, moisture, light, oxygen, pH and formulation conditions can all influence stability.

Stability testing is designed to determine how a peptide changes under defined conditions over a specified period.

Researchers may monitor:

• Peptide purity
• Molecular identity
• Degradation products
• Appearance
• Moisture
• Chemical integrity
• Changes following storage

Different study designs can expose samples to controlled temperature, humidity or light conditions to investigate how environmental factors influence degradation.

Stability data can help researchers establish appropriate storage conditions and understand the shelf-life characteristics of a peptide preparation.

Analytical Chemistry

Analytical chemistry provides the broader framework behind peptide characterisation. Rather than relying on a single measurement, researchers often combine multiple analytical techniques to build a more complete picture of a sample.

A peptide may therefore be investigated using complementary methods such as:

HPLC → separation and purity assessment
Mass spectrometry → molecular mass and identity
Spectroscopic techniques → chemical and structural information
Stability studies → behaviour over time
Chromatographic methods → separation and detection of related compounds

Using multiple analytical approaches provides greater confidence in the identity, composition and quality of a research material.

Why Analytical Characterisation Matters

Biological research is only as reliable as the material being studied. Researchers need to know that the peptide used in an experiment is the intended molecule and understand what else may be present in the sample.

Analytical science therefore sits at the intersection of chemistry, manufacturing and biological research, providing the evidence needed to characterise peptide materials before researchers interpret their biological effects.

Research Insights

Peptide science is developing rapidly, with new studies exploring metabolism, hormones, reproductive biology, skin, ageing, cognition, inflammation and cellular health. Keeping up with the literature can be difficult when research papers are written for specialist audiences.

This section brings emerging research into clearer focus — helping women understand what researchers are studying, what the evidence actually shows and where important questions remain unanswered.

New Peptide Research

New studies can add to, challenge or refine what scientists already understand about peptide biology.

Our research coverage explores developments across areas particularly relevant to women, including:

• Metabolic and hormonal health
• Reproductive biology
• Menstrual and menopausal research
• Skin and connective tissue biology
• Cellular ageing and repair
• Brain and cognitive research
• Inflammation and immune pathways
• Mitochondrial and energy research

Where relevant, we distinguish between laboratory findings, animal studies, observational research and human clinical trials, because the type of evidence matters when interpreting a scientific claim.

Studies Worth Reading

Not every research paper receives the same level of attention, and not every interesting finding represents a meaningful scientific breakthrough.

This collection highlights studies that are particularly useful for understanding peptide science and its potential relevance to female biology.

We look at what the researchers investigated, how the study was designed, what they found and—just as importantly—what the study cannot tell us.

Topics may include research into:

• Female metabolic physiology
• Hormonal signalling
• Reproductive health
• Skin biology and ageing
• Peptide-based therapeutics
• Cellular and mitochondrial function
• Women’s health across the reproductive lifespan

The goal is not simply to collect papers, but to make the most useful research easier to identify and understand.

Research Explained in Plain English

Scientific papers can be difficult to interpret even when the underlying research is sound. Terms such as randomised controlled trial, in vitro, receptor agonist, statistical significance and primary endpoint can make important findings inaccessible to non-specialist readers.

Research Insights translates complex scientific literature into clearer language while retaining the important details.

Each explanation considers questions such as:

What was studied?
The peptide, biological pathway or health question being investigated.

Who or what was studied?
Whether the research involved cells, animals or human participants—and, where relevant, whether women were adequately represented.

What did researchers find?
The principal findings and their scientific significance.

How strong is the evidence?
Whether the results come from early laboratory research or more established human evidence.

What are the limitations?
Important weaknesses, uncertainties or unanswered questions that should be considered before drawing conclusions.

What Changed in the Literature?

Science develops through accumulation of evidence rather than individual studies. A new paper may strengthen an existing hypothesis, produce contradictory results or reveal an entirely new research direction.

This section follows meaningful developments in peptide science and considers how the wider evidence is changing.

For women’s health, this can be particularly important. Research may gradually improve understanding of areas that have historically received less attention, including menstrual biology, menopause, female metabolic health and reproductive physiology.

Rather than presenting every new publication as a breakthrough, we focus on what has genuinely changed—and what has not.

Emerging Areas of Peptide Science

Some of the most interesting areas of peptide research are still developing. Scientists are investigating increasingly complex relationships between peptides, receptors, metabolism, inflammation, cellular energy and tissue biology.

Emerging areas include:

• Multi-pathway metabolic peptides
• Peptides and female reproductive biology
• Menopause-related research
• Peptide approaches to healthy ageing
• Mitochondrial and cellular energy research
• Neurobiology and cognitive research
• Skin regeneration and extracellular matrix biology
• Immune and inflammatory pathways
• Novel peptide drug targets

Early research can be scientifically exciting, but it is also where careful interpretation matters most. A promising mechanism or preliminary result is not the same as established clinical evidence.

Following the Science

Peps4Her Research Insights is designed to help women follow the development of the evidence, rather than simply follow the hype.

We look at what is known, what is being investigated and what remains uncertain—putting peptide research into the wider context of female biology and women’s health.

GHK-Cu: What Does the Research Suggest for Women?

GHK-Cu, also known as copper tripeptide-1, is a naturally occurring peptide complex formed when the tripeptide GHK (glycyl-L-histidyl-L-lysine) binds copper. It has been investigated for decades because of its involvement in skin biology, extracellular-matrix remodelling, tissue repair, inflammation and cellular responses.

Research is particularly interesting in areas relevant to women’s skin and healthy ageing. However, the strength of evidence varies considerably between applications. Much of the broader GHK-Cu literature is preclinical, while human research is concentrated largely around topical cosmetic applications.

1. Skin Firmness & Elasticity

Laboratory research has demonstrated effects on fibroblasts and components of the extracellular matrix, including collagen synthesis in cultured human fibroblasts.

Human cosmetic research has also investigated GHK-Cu-containing creams in women with photoaged skin, with studies reporting improvements in measures including skin firmness, elasticity, skin density, skin thickness, skin laxity, fine lines and wrinkles.

What this means: GHK-Cu has a plausible biological basis and some human cosmetic evidence for supporting the appearance and structural properties of ageing skin, but more robust clinical research is still needed.

2. Collagen & Extracellular Matrix

The extracellular matrix (ECM) provides structural support within the skin. It contains collagen, elastin, glycosaminoglycans and other components that contribute to skin strength, elasticity and organisation.

GHK-Cu has been studied extensively in this area. Research has investigated collagen synthesis, fibroblast activity, glycosaminoglycans and enzymes involved in extracellular-matrix remodelling.

• Collagen synthesis
• Extracellular-matrix organisation
• Fibroblast activity
• Tissue remodelling
• Skin firmness and elasticity

This is one of the strongest mechanistic areas of GHK-Cu research, although cellular findings should not automatically be interpreted as equivalent to clinical outcomes.

3. Fine Lines & Wrinkles

GHK-Cu has been investigated as a peptide for photoaged and ageing skin. Human cosmetic studies in women have reported improvements in skin density and thickness alongside reductions in skin laxity, fine lines and wrinkle depth following topical use.

These findings are encouraging, but formulation matters. A peptide’s performance in a laboratory experiment does not necessarily predict the performance of every cosmetic formulation containing that peptide.

4. Skin Repair & Tissue Remodelling

GHK-Cu has attracted considerable research interest because of its potential involvement in tissue repair and remodelling. Laboratory and preclinical studies have investigated fibroblasts, collagen production, extracellular-matrix components and growth-factor pathways.

• Fibroblast activity
• Collagen production
• Extracellular-matrix remodelling
• Cell migration
• Growth-factor expression
• Tissue regeneration

Much of this evidence is preclinical. GHK-Cu’s regenerative mechanisms are scientifically interesting, but this does not establish it as a clinically proven treatment for wounds or injuries.

5. Skin Barrier & Skin Quality

The skin barrier helps maintain hydration while protecting underlying tissue from environmental exposure. Research into GHK-Cu has investigated cellular processes involved in skin structure, extracellular-matrix organisation and tissue repair.

• Skin integrity
• Hydration
• Barrier function
• Extracellular-matrix organisation
• Recovery following environmental stress

The evidence is still developing, and effects observed with a particular formulation cannot necessarily be attributed to GHK-Cu alone.

6. Photoageing & Pigmentation

GHK-Cu has been investigated in relation to photoaged skin, with human cosmetic studies reporting improvements in several visible measures of ageing skin, including fine lines, wrinkles, skin density and pigmentation-related appearance.

This makes GHK-Cu particularly interesting within research into healthy skin ageing in women. However, GHK-Cu should not be considered a replacement for established photoprotection such as sunscreen.

7. Inflammation Research

Inflammation is closely connected with tissue injury, ageing and repair. Preclinical research has investigated whether GHK-Cu can influence inflammatory mediators and pathways involved in tissue responses.

Researchers are interested in whether these properties could help explain some of GHK-Cu’s observed effects on tissue repair and skin biology.

Important: anti-inflammatory activity in a laboratory model does not establish that GHK-Cu treats an inflammatory disease in humans.

8. Oxidative Stress & Cellular Protection

Cells naturally produce reactive oxygen species (ROS) during normal metabolism. Excessive oxidative stress can damage cellular proteins, lipids and DNA.

GHK-Cu has been investigated for potential antioxidant and cellular protective effects in preclinical research, contributing to interest in its possible role in skin ageing and tissue maintenance.

• Reactive oxygen species
• Cellular stress
• Antioxidant defence
• Mitochondrial processes
• Tissue ageing

9. Hair & Hair-Follicle Research

GHK-Cu has also been investigated in relation to hair biology. Preclinical research has examined effects on fibroblasts, tissue remodelling and hair-follicle biology, generating interest in hair and scalp research.

• Hair-follicle biology
• Tissue repair
• Cellular proliferation
• Scalp skin biology

Evidence for GHK-Cu as a treatment for female hair loss is considerably less established than the evidence surrounding topical skin applications.

10. Cellular Regeneration

Researchers have investigated GHK-Cu’s influence on fibroblast and keratinocyte activity, collagen synthesis, extracellular-matrix remodelling and growth-factor expression.

These findings provide a biological rationale for further investigation into GHK-Cu as a regenerative peptide, but mechanistic evidence is not the same as demonstrated clinical benefit.

11. Healthy Ageing Research

GHK-Cu has increasingly attracted attention within the broader field of healthy ageing. Its proposed mechanisms—including extracellular-matrix regulation, tissue remodelling, inflammatory pathways and oxidative-stress responses—have led researchers to investigate whether it could have applications beyond cosmetic skincare.

• Skin ageing
• Cellular ageing
• Tissue regeneration
• Inflammation
• Oxidative stress
• Extracellular-matrix maintenance

Claims that GHK-Cu can extend lifespan, reverse biological ageing or prevent age-related disease are not established by current human evidence.

What Does the Evidence Actually Show?

GHK-Cu is a particularly interesting peptide because there is a substantial body of mechanistic and preclinical research alongside a smaller body of human cosmetic research.

The strongest areas of interest currently include skin biology, collagen and extracellular-matrix regulation, tissue remodelling and photoaged skin. Human studies have reported improvements in several measures of skin appearance, particularly with topical formulations.

Important evidence gaps remain. Recent reviews highlight the limited number of robust clinical studies and the importance of formulation, chemical stability and delivery method when interpreting research findings.

The Peps4Her Takeaway

GHK-Cu is scientifically interesting—not because every claim made about it has been proven, but because its underlying biology gives researchers multiple mechanisms worth investigating.

For women, the most relevant research currently centres around skin ageing, collagen, extracellular-matrix biology, tissue repair and cellular health.

The distinction between promising research and proven clinical benefit matters. Peps4Her follows the evidence as it develops and separates established findings from early-stage or speculative claims.

Key Research

• GHK-Cu and collagen synthesis in human fibroblasts — PubMed
• GHK-Cu and tissue remodelling — PubMed
• GHK-Cu and topical anti-ageing research — PubMed
• Systematic review of GHK-Cu in aesthetic medicine — PubMed
• GHK-Cu and skin ageing research — PMC
• GHK-Cu biology and healthy ageing review — PMC

BPC-157: What Does the Research Suggest for Women?

BPC-157, also known as body protection compound-157 or pentadecapeptide BPC-157, is a 15-amino-acid peptide that has attracted research interest because of reported effects on tissue repair, inflammation, vascular biology and gastrointestinal integrity.

The evidence base is substantially more preclinical than clinical. A 2025 systematic review identified 36 relevant studies, of which 35 were preclinical and only one was clinical. Preclinical research has produced promising findings across several injury and tissue models, but this does not establish BPC-157 as an effective or safe treatment in humans.

For women specifically, there is currently no strong evidence establishing sex-specific benefits. Most BPC-157 research has not been designed around female biology or women’s health.

1. Tendon & Ligament Research

One of the most extensively investigated areas is musculoskeletal tissue repair. Experimental studies in animals have examined BPC-157 in models of Achilles tendon injury, medial collateral ligament injury and tendon-to-bone healing.

Researchers are investigating:

• Tendon healing
• Ligament repair
• Collagen organisation
• Fibroblast and tendocyte activity
• Tissue remodelling
• Functional recovery
• Tendon-to-bone healing

These findings provide a rationale for further investigation, but animal results cannot be assumed to predict the same effect in humans.

2. Muscle Injury & Recovery

Experimental skeletal-muscle injury models have investigated whether BPC-157 influences tissue regeneration and recovery following injury.

Areas of research include:

• Muscle regeneration
• Fibroblast activity
• Cellular repair
• Angiogenesis
• Tissue remodelling
• Functional recovery
• Inflammatory signalling

Results are predominantly preclinical. There is not currently enough controlled human evidence to determine whether these effects translate into meaningful clinical recovery.

3. Wound Healing & Tissue Repair

BPC-157 has been investigated in experimental models of wound healing and tissue injury. Researchers have explored possible effects on fibroblasts, collagen, cell migration, vascular responses and inflammatory pathways.

Research areas include:

• Fibroblast activity
• Collagen and extracellular-matrix processes
• Cell migration
• Blood-vessel formation
• Inflammatory responses
• Tissue remodelling

These studies are useful for understanding biological mechanisms, but they do not establish BPC-157 as a clinically proven wound-healing treatment.

4. Angiogenesis & Vascular Research

Angiogenesis—the formation of new blood vessels—is an important component of tissue repair. BPC-157 research has investigated vascular responses and signalling pathways associated with angiogenesis, including VEGF-related mechanisms.

Researchers are examining:

• VEGF signalling
• Blood-vessel formation
• Endothelial responses
• Tissue vascularisation
• Injury-associated angiogenesis
• Vascular remodelling

Mechanistic and animal findings are scientifically interesting, but they do not establish a human vascular therapy.

5. Inflammation Research

Inflammation is involved in injury, tissue repair and many chronic diseases. Preclinical BPC-157 studies have reported changes in inflammatory signalling and cytokine activity.

Research includes:

• Inflammatory cytokines
• Immune signalling
• Tissue inflammation
• Cellular stress responses
• Resolution of inflammatory responses

Important: anti-inflammatory activity in laboratory or animal models does not establish that BPC-157 treats an inflammatory disease in humans.

6. Gastrointestinal & Gut Research

BPC-157 was originally associated with gastric biology and has been investigated extensively in experimental models involving the gastrointestinal tract.

Areas of research include:

• Gastric mucosal integrity
• Intestinal tissue responses
• Gastrointestinal injury
• Tissue repair
• Inflammatory responses
• Vascular responses

Interest has also extended to experimental models relevant to intestinal inflammation. These findings remain primarily preclinical and should not be interpreted as evidence that BPC-157 is an established treatment for gastrointestinal disease.

7. Nerve & Neurological Research

Experimental research has investigated BPC-157 in models involving the nervous system and neural injury.

Research areas include:

• Nerve regeneration
• Neuronal signalling
• Neural repair
• Neuroinflammation
• Vascular responses
• Neuromuscular function

This remains a highly experimental field. Evidence from cellular and animal models cannot be used to establish neurological benefits in humans.

8. Cellular Protection & Stress Responses

BPC-157 has been studied in relation to cellular stress, oxidative injury, nitric oxide signalling and tissue homeostasis.

Researchers are investigating:

• Cellular stress responses
• Oxidative stress
• Nitric oxide signalling
• Cellular survival
• Tissue homeostasis
• Inflammatory regulation

These mechanisms may help explain findings observed in preclinical models, but human validation remains a major gap.

9. Bone & Joint Research

Animal research has investigated BPC-157 in bone, joint and tendon-to-bone models, including experimental injuries affecting musculoskeletal tissues.

Areas of investigation include:

• Tendon-to-bone healing
• Bone repair
• Joint tissue responses
• Collagen and matrix biology
• Vascular responses
• Tissue remodelling

The majority of evidence remains animal-based, so the clinical relevance to human orthopaedic conditions remains uncertain.

10. Regenerative Medicine Research

BPC-157 has attracted attention within regenerative medicine because research spans several biological systems rather than a single tissue type.

Research interests include:

• Tendon regeneration
• Ligament repair
• Muscle recovery
• Tissue remodelling
• Angiogenesis
• Cellular repair
• Inflammatory regulation
• Gastrointestinal tissue integrity

The breadth of preclinical research is scientifically interesting, but major translational barriers remain, including limited human evidence, incomplete pharmacokinetic understanding and the absence of a validated clinical formulation and dosing regimen.

11. Women’s Health & Female Biology

There is currently no established evidence that BPC-157 provides a female-specific clinical benefit.

Most studies have not been designed to answer questions about sex differences or women’s health. There is no established clinical evidence supporting BPC-157 for female hormonal health, menstrual symptoms, menopause, PCOS, fertility or female-specific metabolic health.

Its potential relevance to women currently comes primarily from general biological systems—such as tissue repair, inflammation and vascular biology—that can affect people of either sex.

What Does the Evidence Actually Show?

Preclinical research into BPC-157 is broad and generally promising, particularly in experimental models of musculoskeletal injury, tissue repair, vascular responses and inflammation.

However, the human evidence is extremely limited. The 2025 systematic review identified 36 studies, including 35 preclinical studies and one clinical study. The clinical study was a small retrospective report in which 7 of 12 patients with chronic knee pain reported relief lasting more than six months after an intra-articular injection.

More recent 2026 review literature describes human clinical data as fewer than 30 subjects across three uncontrolled pilot studies, with no completed Phase II trial and no validated dosing regimen or pharmaceutical-grade formulation. These limitations make it impossible to draw reliable conclusions about efficacy or long-term safety in humans.

The Peps4Her Takeaway

BPC-157 is scientifically interesting because preclinical research has identified multiple potential mechanisms involving tissue repair, vascular biology, inflammation and cellular responses.

The strongest research signal currently lies in experimental musculoskeletal and tissue-repair models. However, the gap between promising animal research and established human clinical evidence remains substantial.

For women, there is currently no established female-specific benefit. Peps4Her therefore distinguishes between preclinical promise and clinical proof, and treats BPC-157 as an investigational research subject rather than an established treatment.

Key Research

• BPC-157 in orthopaedic sports medicine: systematic review — PubMed
• BPC-157 and Achilles tendon healing — PubMed
• BPC-157 and ligament healing — PubMed
• BPC-157, angiogenesis and muscle/tendon healing — PubMed
• BPC-157 and tendon-to-bone healing — PubMed
• BPC-157 as an investigational peptide therapeutic — PubMed
• BPC-157 literature and patent review — PubMed

Glutathione: What Does the Research Suggest for Women?

Glutathione (GSH) is a naturally occurring tripeptide made from glutamate, cysteine and glycine. It is one of the body’s major intracellular antioxidants and plays a central role in redox balance, cellular protection and several detoxification pathways.

Research spans cellular biology, oxidative stress, metabolism, skin science, healthy ageing, immune function and reproductive biology. Unlike many emerging peptides, glutathione is an endogenous molecule with an established physiological role. However, the clinical effects of increasing glutathione depend on the condition being studied, formulation, route of administration and population.

1. Antioxidant & Redox Biology

Glutathione is a major component of the cell’s antioxidant defence system. Researchers study the balance between reduced glutathione (GSH) and oxidised glutathione (GSSG) as an indicator of cellular redox status.

• Oxidative stress
• Reactive oxygen species (ROS)
• Redox signalling
• Protection of proteins, lipids and DNA
• Cellular antioxidant defence

Its established biological role does not automatically mean that increasing glutathione produces clinical benefits in people who already have adequate levels.

2. Cellular Protection & Repair

Glutathione is involved in cellular responses to oxidative and metabolic stress. Research has investigated its relationship with protein protection, lipid oxidation, DNA damage, mitochondrial function and redox-sensitive signalling.

3. Skin Biology & Healthy Ageing

Glutathione has attracted considerable interest in dermatological research because oxidative stress and redox biology are connected with pigmentation, photoageing and skin-cell function.

• Melanin production
• Oxidative stress
• Skin brightness and pigmentation
• Hydration and barrier function
• Photoageing
• Visible signs of skin ageing

A 2025 systematic review of topical glutathione identified five clinical trials and described the findings as promising while highlighting the need for larger, better-controlled studies.

4. Melanin & Pigmentation Research

Glutathione has been investigated for its effects on melanogenesis and tyrosinase-related pathways. Human research has examined outcomes including melanin indices, pigmentation and hyperpigmentation.

A 2025 systematic review found that several oral and topical studies reported reductions in pigmentation measures, but study quality and risk of bias varied. This should not be interpreted as evidence that glutathione is a universally established skin-lightening treatment.

5. Oxidative Stress & Mitochondrial Research

Because mitochondria generate reactive oxygen species as part of normal energy metabolism, glutathione is relevant to research into mitochondrial oxidative stress and cellular resilience.

• Mitochondrial oxidative stress
• Cellular energy metabolism
• Reactive oxygen species
• Redox signalling
• Cellular ageing

Research into these mechanisms is scientifically important, but anti-ageing outcomes in humans have not been established.

6. Metabolic & Cardiometabolic Research

Researchers have investigated glutathione status in relation to insulin sensitivity, glucose metabolism, oxidative stress, inflammation and cardiometabolic dysfunction.

Systematic reviews of interventions affecting glutathione status have reported heterogeneous findings. The evidence is not sufficient to establish glutathione as a general treatment for metabolic disease.

7. Liver & Detoxification Research

Glutathione is directly involved in hepatic redox balance and enzymatic detoxification pathways, including glutathione-S-transferase activity and the metabolism of certain endogenous and foreign compounds.

• Hepatic antioxidant defence
• Xenobiotic metabolism
• Glutathione-S-transferases
• Oxidative liver injury
• Cellular detoxification pathways

The biochemical role of glutathione is well established, but broad consumer claims about “detoxing the body” often extend beyond what the underlying research actually demonstrates.

8. Immune & Inflammatory Research

Glutathione participates in immune-cell redox balance and has been studied in relation to inflammatory signalling and cellular defence.

• Immune-cell activity
• Oxidative stress
• Inflammatory signalling
• Cytokine pathways
• Cellular defence

Altered glutathione status has been observed in several disease states, but whether directly changing glutathione levels improves those conditions remains unresolved.

9. Reproductive & Fertility Research

Reproductive biology is another area of interest because oxidative balance is important in oocyte maturation, follicular biology and early embryo development.

• Oocyte quality
• Follicular-fluid redox balance
• Embryo development
• Granulosa-cell biology
• Reproductive ageing

Research in IVF has identified relationships between glutathione-dependent antioxidant systems and oocyte or embryo quality. These findings provide biological rationale for further research, but association does not establish that glutathione supplementation improves fertility or IVF outcomes.

10. Glutathione & PCOS Research

Oxidative stress and altered antioxidant systems have been investigated extensively in polycystic ovary syndrome (PCOS). Researchers have examined glutathione-related enzymes and redox pathways in relation to ovarian and reproductive biology.

• Glutathione status
• Glutathione peroxidase and reductase
• Oxidative stress
• Oocyte and embryo biology
• Follicular environment

This research provides a rationale for studying redox biology in PCOS, but it does not establish glutathione as a treatment for PCOS.

11. Oral Glutathione Research

Human research has examined whether orally administered glutathione can increase glutathione stores. In a six-month randomized, double-blind, placebo-controlled trial involving 54 healthy adults, oral glutathione increased glutathione measures in several body compartments. Some effects diminished after a washout period.

This distinction is important: evidence that an intervention increases glutathione levels is not the same as evidence that it produces a meaningful clinical outcome.

12. Topical Glutathione Research

Topical formulations have been studied in relation to pigmentation, melanin, skin brightness, UV responses, hydration, transepidermal water loss and visible skin ageing.

Recent systematic reviews describe the findings as promising but limited by small studies, differing formulations and the need for larger randomized controlled trials.

13. Systemic & Injectable Glutathione Research

Systemic glutathione research includes investigations into antioxidant biology and pigmentation. Evidence surrounding intravenous glutathione for cosmetic skin-lightening is substantially less robust than its established physiological role, with important questions around efficacy, formulation and safety.

Peps4Her does not present injectable glutathione as an established cosmetic or health intervention.

14. Healthy Ageing Research

Glutathione is being investigated within healthy-ageing research because oxidative stress, mitochondrial function, inflammation and cellular resilience all change with age.

• Oxidative stress
• Mitochondrial function
• Inflammation
• Skin ageing
• Cellular resilience
• Tissue maintenance

Evidence that glutathione supplementation slows biological ageing, prevents age-related disease or extends lifespan remains insufficient.

What Does the Evidence Actually Show?

The strongest established point is glutathione’s biological role in cellular redox regulation. Human research also supports the possibility of increasing glutathione stores through oral supplementation, while dermatological research provides preliminary evidence around pigmentation and some skin-quality outcomes.

Important evidence gaps remain. Studies vary substantially in dose, formulation, route, population and outcome measures, and relatively small clinical studies make it difficult to generalise findings.

The Peps4Her Takeaway

Glutathione is scientifically important because it is a naturally occurring cellular antioxidant involved in redox balance, detoxification pathways, immune biology and cellular protection.

For women, the most relevant research interests currently include skin pigmentation, healthy ageing, oxidative stress, reproductive biology and PCOS-related redox research.

The distinction between biological role, association and demonstrated clinical benefit matters. Peps4Her follows the evidence as it develops and separates established physiology from preliminary or speculative claims.

Key Research

• Glutathione and skin pigmentation/melasma systematic review — PubMed
• Topical glutathione systematic review — PubMed
• Systemic glutathione and skin-lightening scoping review — PubMed
• Glutathione, skin ageing and tissue regeneration systematic review — PubMed
• Oral glutathione randomized controlled trial — PubMed
• Glutathione-dependent enzymes, oocytes and embryos in PCOS — PubMed
• Redox status and reproductive outcomes in PCOS — PubMed
• Systematic review of supplements and plasma glutathione in diabetes — PubMed

Selank: What Does the Research Suggest for Women?

Selank is a synthetic peptide derived from the naturally occurring immunoregulatory peptide tuftsin. It has been investigated primarily in Russia as an experimental neuropeptide, with research focusing on anxiety, stress responses, cognition, neurotransmitter systems and immune signalling.

Selank is sometimes described online as an anxiolytic or nootropic peptide. Human studies have reported potentially relevant effects, but the clinical evidence base is limited compared with established treatments, and independent contemporary replication is lacking. Peps4Her therefore distinguishes between early human findings, mechanistic research and established clinical evidence.

1. Anxiety & Stress Research

Anxiety is the area in which Selank has received the most direct human research attention. Clinical studies have investigated its effects in people with anxiety and anxiety-asthenic disorders.

• Anxiety symptoms
• Stress responses
• Anxiety-phobic disorders
• Asthenic symptoms
• Quality of life

A 2008 study of 62 patients with generalized anxiety disorder and neurasthenia reported anxiolytic effects comparable to medazepam, alongside reported antiasthenic and psychostimulant effects. A later 2014 comparative clinical trial involving 60 patients also reported anxiolytic and mild nootropic effects. These findings are of scientific interest, but the studies were relatively small and are not sufficient to establish Selank as an evidence-based treatment for anxiety disorders.

2. Neurobiology & GABAergic Signalling

Selank has been investigated in relation to GABAergic signalling and other neurotransmitter systems. GABA is the principal inhibitory neurotransmitter in the central nervous system and is also involved in immune regulation.

Research has explored whether Selank may influence GABA-related pathways and downstream neurochemical signalling. The precise human mechanism of action remains incompletely established, and mechanistic findings should not be interpreted as proof of a particular clinical effect.

3. Cognitive & Nootropic Research

Selank has been studied for potential effects on cognitive and behavioural functions, particularly alongside research into anxiety and stress.

• Attention and cognitive performance
• Memory-related processes
• Stress-associated cognitive changes
• Learning and behavioural responses
• Nootropic effects

Some human studies have reported mild nootropic or psychostimulant effects, while much of the mechanistic literature remains preclinical. There is not enough high-quality evidence to establish Selank as a clinically proven cognitive enhancer.

4. Stress Biology & Adaptation

Experimental research has investigated Selank in models of acute and social stress. Researchers have examined behavioural responses alongside changes in neurochemical and inflammatory signalling.

These studies are relevant to understanding how neuropeptides may influence the biological response to stress, but animal stress models cannot establish that Selank improves stress-related disorders in humans.

5. Immune & Cytokine Research

Selank has also been investigated for potential immunomodulatory activity. Research has examined changes in cytokines, chemokines and genes involved in immune signalling.

• IL-6 and other cytokines
• Chemokine signalling
• Th1/Th2 immune balance
• Inflammatory gene expression
• Immune-cell responses

Human and animal studies have reported changes in immune-related markers following Selank exposure. These findings are mechanistically interesting, but they do not establish Selank as a treatment for inflammatory, autoimmune or infectious disease.

6. Neuroimmune Research

The nervous and immune systems communicate through overlapping signalling pathways. Selank research has explored this interface because the peptide has reported effects in both behavioural and immune-related models.

Researchers are interested in whether neuropeptide signalling can influence cytokine activity, stress responses and neuroimmune communication. This remains an emerging research area rather than an established therapeutic application.

7. Serotonin, Dopamine & Neurotransmitter Research

Selank research has examined changes in neurotransmitter-related systems associated with mood, stress and behaviour.

• GABAergic signalling
• Serotonergic pathways
• Dopaminergic signalling
• Enkephalin-related pathways
• Stress-related neurochemical responses

Because these systems interact extensively, observed changes do not necessarily identify a single mechanism responsible for Selank’s reported effects.

8. Enkephalin & Endogenous Peptide Research

Clinical research has examined Selank alongside measurements of endogenous opioid-related peptides, including leu-enkephalin. One study reported changes in enkephalin-related measures during treatment in patients with anxiety and neurasthenia.

These findings may help researchers investigate how synthetic regulatory peptides interact with endogenous signalling systems, but they do not establish a direct therapeutic mechanism.

9. Inflammation & Gene-Expression Research

Preclinical studies have investigated Selank and its fragments in relation to genes involved in inflammation. Experimental work in mice has reported changes in expression of cytokines, chemokines and their receptors following exposure.

This type of research can identify biological pathways for further investigation, but altered gene expression in an animal model is not evidence that Selank treats inflammation in humans.

10. Women’s Health & Female Biology

There is currently no established evidence that Selank provides a female-specific clinical benefit.

Most Selank studies have not been designed specifically around women’s health, menstrual-cycle biology, menopause, PCOS, fertility or female-specific metabolic physiology. Its potential relevance to women currently comes primarily from general research into anxiety, stress, neurobiology and immune signalling.

11. Sleep & Stress-Related Research

Because Selank has been investigated in anxiety and stress models, researchers have considered behavioural outcomes that can overlap with sleep and stress regulation.

However, evidence is insufficient to establish Selank as a treatment for insomnia or other sleep disorders. Claims about improving sleep should therefore be treated as preliminary rather than established clinical effects.

12. Pharmacology & Safety Research

Selank is pharmacologically distinct from conventional small-molecule anxiolytics. Its peptide structure and proposed neuroactive mechanisms have prompted research into pharmacology, tolerability and biological activity.

The available human literature is limited, and modern large-scale randomized trials, standardized formulations and long-term safety data are lacking. A 2021 pharmacology review described Selank as poorly studied and highlighted the need for further evaluation of GABA-modulating agents.

Consequently, the absence of a large reported safety signal should not be interpreted as proof of long-term safety.

13. Human Clinical Research

Human studies have primarily investigated Selank in anxiety and anxiety-asthenic disorders. A 2008 clinical study included 62 patients, while a 2014 comparative trial included 60 patients. Another study investigated Selank alongside phenazepam in 70 patients with anxiety-related disorders.

These studies provide early human evidence worth documenting, but limitations include small sample sizes, limited independent replication, older study designs and a concentration of research from a relatively narrow geographical and scientific literature base.

14. What Does the Evidence Actually Show?

The strongest human research signal is in anxiety-related symptoms. Several clinical studies have reported anxiolytic effects, with some also reporting cognitive or antiasthenic effects.

However, the overall evidence base remains limited. Mechanistic and animal research suggests possible effects involving GABAergic, neurochemical and immune pathways, but these mechanisms have not been sufficiently validated in modern clinical trials.

There is currently insufficient evidence to conclude that Selank is an established treatment for anxiety, depression, cognitive impairment, sleep disorders, inflammation or women-specific conditions.

The Peps4Her Takeaway

Selank is an investigational neuropeptide with its strongest published human research signal in anxiety and stress-related conditions.

Its proposed relevance to women comes primarily through broader research into stress biology, neurobiology and immune signalling rather than established female-specific clinical benefits.

Peps4Her distinguishes between early human evidence, preclinical mechanism and demonstrated clinical efficacy. Selank remains an emerging research subject rather than an established medical or cognitive treatment.

Key Research

• Selank in generalized anxiety disorder and neurasthenia — PubMed
• Selank compared with phenazepam in anxiety disorders — PubMed
• Selank and phenazepam in anxiety disorders — PubMed
• Immunomodulatory effects of Selank — PubMed
• Selank and cytokines under social stress — PubMed
• Selank and inflammation-related gene expression — PubMed
• Selank, cytokines and chemokine-related gene expression — PubMed
• Review of GABA-related pharmacology including Selank — PubMed

Semax: What Does the Research Suggest for Women?

Semax is a synthetic heptapeptide derived from the ACTH(4–7) sequence with a C-terminal Pro-Gly-Pro component. It has been investigated primarily as a neuroactive and neuroprotective peptide, particularly in Russia.

Research has examined Semax in areas including neurological recovery, neuroprotection, cognitive function, neurotrophin signalling, neuroinflammation and brain-network activity. Semax is sometimes described online as a nootropic, cognitive enhancer or neuroprotective peptide. Peps4Her separates these claims from what has actually been demonstrated in human research.

1. Neuroprotection Research

One of the major research areas for Semax is protection of neural tissue from injury. Researchers have investigated neuronal survival, cerebral ischaemia, oxidative stress, inflammatory signalling, neuronal recovery and neurotrophin pathways.

Much of the mechanistic evidence comes from animal and cellular models. These findings are biologically interesting but do not by themselves establish clinical neuroprotection in humans.

2. Ischaemic Stroke Research

Stroke is one of the areas where Semax has accumulated human clinical research. A 2018 study involving 110 patients following ischaemic stroke investigated Semax alongside rehabilitation. The study reported increased plasma BDNF levels and improvements in functional recovery measured using the Barthel Index.

Earlier clinical research has also investigated Semax during acute and recovery phases of ischaemic stroke. However, the evidence base has important limitations, including study design, reporting quality, relatively small individual studies and limited independent replication.

3. BDNF & Neurotrophin Research

One of the most frequently investigated mechanisms associated with Semax is brain-derived neurotrophic factor (BDNF). Experimental research has examined BDNF expression, TrkB signalling, NGF expression and other neurotrophin pathways.

Animal studies have demonstrated changes in BDNF and TrkB following Semax exposure, while clinical stroke research has reported increased circulating BDNF alongside functional recovery. Increased BDNF does not automatically mean improved cognition or neurological function in humans.

4. Cognitive & Memory Research

Semax has been investigated for potential effects on learning, memory, attention, cognitive performance, stress-associated cognitive changes and neural plasticity.

Animal research has reported effects on learning and memory, including changes associated with hippocampal BDNF/TrkB signalling. Limited human research has also examined neurological and cognitive effects. Evidence is not currently strong enough to describe Semax as an established cognitive-enhancing treatment.

5. Brain Network & Neuroimaging Research

A 2018 functional MRI study examined resting-state brain activity in 24 healthy volunteers, including 13 women and 11 men. Researchers reported changes in functional brain-network activity following Semax exposure.

This provides evidence that Semax can produce measurable changes in brain activity, but neuroimaging changes are biological observations rather than proof of clinical cognitive benefit.

6. Neuroinflammation & Immune Signalling

Semax has been investigated in relation to neuroimmune signalling, including inflammatory gene expression, cytokine-related pathways and immune-response genes.

Experimental stroke research has reported changes in inflammatory and immune-related gene expression. This research helps identify pathways for further investigation, but does not establish Semax as a treatment for inflammatory disease in humans.

7. Oxidative Stress & Cellular Protection

Experimental studies have investigated whether Semax can influence oxidative damage, neuronal survival, cellular stress responses and inflammatory signalling.

Animal-model research suggests that Semax may reduce some pathological responses associated with neurological injury. These findings remain mechanistic rather than proof of a clinically established antioxidant effect in humans.

8. Neurodegenerative Disease Research

Semax has been explored in research relevant to neurodegeneration and Alzheimer’s disease. Laboratory research has investigated its interaction with amyloid-beta aggregation, including copper-associated amyloid formation.

These biochemical findings are scientifically interesting but are far removed from demonstrating an Alzheimer’s treatment in humans.

9. Spinal Cord Injury & Regenerative Neuroscience

A 2025 study investigated Semax in female mice with spinal cord injury. Researchers reported improved functional recovery alongside changes in oxidative stress, neuroinflammatory signalling and pyroptosis, and proposed involvement of μ-opioid receptor/USP18-related pathways.

This is notable from a women’s-health research perspective because the experimental model specifically used female animals. However, female-mouse research remains preclinical evidence and cannot be translated directly into human therapeutic benefit.

10. Women & Female Biology

Semax has not been adequately studied as a women-specific peptide.

There is currently insufficient evidence to establish benefits for menstrual health, menopause, PMDD, PCOS, fertility, female metabolic physiology or female-specific neurological conditions. Most Semax studies have not been designed specifically around women’s health.

The most relevant female-specific development is currently preclinical research, including recent work in female mice following spinal cord injury. This does not establish a human women’s-health indication.

11. Neurological Recovery & Motor Function

Human research has examined Semax in neurological rehabilitation, particularly following stroke. The 2018 study of 110 post-stroke patients reported improvements in functional recovery and motor outcomes alongside increased BDNF.

Another human study investigated Semax in motor-neuron disease. It did not demonstrate an improvement in the underlying course of motor-neuron disease, although researchers reported improvements in some quality-of-life measures related to emotional state and motivation.

This illustrates why individual outcomes need to be separated from claims about disease modification.

12. Human Clinical Evidence

Human research exists, but its limitations are important. Published studies have investigated Semax in ischaemic stroke, neurological rehabilitation, motor-neuron disease, cognitive and neurological function and healthy-volunteer neuroimaging.

Some studies report potentially beneficial effects, particularly around neurological recovery following stroke. However, much of the literature originates from Russia, many studies are relatively small, and independent replication using contemporary international trial standards remains limited.

13. Safety & Pharmacology Research

Semax has been investigated for decades, but its safety evidence should not be confused with the extensive safety databases available for approved medicines.

• Large modern randomised trials remain limited
• Long-term safety data are limited
• Independent international replication is limited
• Standardised clinical formulations vary
• Robust dose-ranging research is limited
• Reproductive and pregnancy-specific safety research is limited

The absence of extensive reported adverse-event data should not be interpreted as proof of long-term safety.

14. What Does the Evidence Actually Show?

The strongest research signal for Semax is currently concentrated around neurological and neuroprotective research, particularly ischaemic stroke and experimental models of neural injury.

Human research provides some clinical evidence, while mechanistic studies have investigated BDNF/TrkB, NGF, neuroplasticity, inflammatory signalling, oxidative stress and brain-network activity. The overall certainty remains limited because of study design, reporting and replication issues.

There is currently insufficient evidence to conclude that Semax is an established treatment for cognition, neurological disease, inflammation, neurodegeneration or women-specific conditions.

The Peps4Her Takeaway

Semax is an investigational neuroactive peptide with a substantial body of published Russian research and a growing preclinical literature.

Its most interesting research areas include neuroprotection, stroke recovery, BDNF/neurotrophin signalling, cognition, neuroinflammation and neural repair.

There are genuine human studies, meaning Semax should not be presented as purely experimental animal research. However, the human evidence is not yet strong enough to classify Semax as an established treatment for cognition, neurological disease, inflammation or women’s health.

For women specifically, the research gap is substantial. Peps4Her therefore presents Semax primarily as an investigational neurobiology peptide and distinguishes biological plausibility from clinical proof.

Key Research

• Semax and ischaemic stroke — PubMed
• Semax and motor-neuron disease — PubMed
• Semax and BDNF/TrkB signalling — PubMed
• Semax and neurotrophin expression — PubMed
• Semax and brain-network activity — PubMed
• Semax and neuroimmune signalling — PubMed
• Semax and amyloid-beta research — PubMed
• Semax in female mice with spinal cord injury — PubMed

Thymalin: What Does the Research Suggest for Women?

Thymalin is a polypeptide preparation derived from thymic tissue and investigated primarily in relation to immune regulation, T-cell function, inflammation and age-related immune biology. It has a long history of research, particularly in Russian biomedical literature.

Thymalin is sometimes discussed online alongside other thymic peptides and longevity research. Peps4Her distinguishes between the biological rationale for studying thymic peptides and evidence demonstrating a proven clinical benefit.

1. Immune System Research

The thymus is central to the development and maturation of T lymphocytes. Thymic peptides have therefore been investigated for their potential effects on immune-cell differentiation, immune signalling and restoration of immune function.

Research has examined whether Thymalin can influence immune responses in settings associated with ageing, illness or immune dysfunction. Much of this literature is older and comes from a relatively concentrated research base.

2. T-Cell & Cellular Immunity Research

Thymic peptide research has focused on T-cell differentiation and maturation, lymphocyte function and communication between immune-cell populations.

Experimental and clinical studies have reported changes in lymphocyte-related measures following thymic peptide exposure. These findings are relevant to immunology, but changes in immune markers do not automatically demonstrate improved clinical outcomes.

3. Immunomodulation Research

Thymalin has been investigated as an immunomodulatory rather than simply an immune-stimulating agent. Researchers have explored whether thymic peptides can influence immune responses toward greater physiological balance.

• T-cell activity
• Lymphocyte differentiation
• Phagocytic and innate immune responses
• Cytokine-related signalling
• Immune recovery following illness

The concept of immunomodulation is important because immune biology involves tightly regulated feedback systems rather than a simple requirement to increase immune activity.

4. Ageing & Immunosenescence Research

Ageing is associated with changes in thymic structure and immune function, including reduced thymic activity and alterations in T-cell populations. This process is known as immunosenescence.

Thymalin has therefore been investigated in research examining whether thymic peptides could influence age-related changes in immune function. This is one of the major reasons the peptide appears in longevity-related research.

However, evidence that a biological marker changes with treatment is not equivalent to evidence that a peptide extends healthy lifespan or prevents age-related disease.

5. Longevity & Geroprotective Research

Thymalin has appeared in studies examining longevity and so-called geroprotective effects. Some older Russian studies investigated thymic peptide preparations alongside other peptide bioregulators in older adults.

These studies are historically interesting but do not meet the evidentiary standard required to establish Thymalin as a proven longevity intervention. Modern, large, independently replicated trials measuring clinically meaningful lifespan or healthspan outcomes are lacking.

6. Inflammation Research

Because thymic peptides interact with immune signalling, researchers have investigated their relationship with inflammatory pathways and cytokine activity.

Research has explored whether thymic peptides can influence inflammatory responses and immune balance. The biological rationale is plausible, but evidence remains insufficient to establish Thymalin as a treatment for chronic inflammatory disease.

7. Neuroendocrine & Immune Signalling

The thymus is part of a wider neuroendocrine-immune network. Research has investigated communication between thymic hormones, the nervous system and endocrine signalling.

This work is relevant to understanding how immune function interacts with stress, hormonal regulation and broader physiological systems. It does not, however, establish a specific therapeutic effect of Thymalin on neurological or endocrine disorders.

8. Respiratory & Immune Research

Thymic peptides have been investigated in respiratory disease and immune responses to infection. Historical clinical literature includes studies of thymic preparations in non-specific lung disease and more recent research has examined Thymalin in the context of severe respiratory infection.

These studies provide areas for further investigation, but the available evidence is not sufficient to establish Thymalin as an evidence-based treatment for respiratory infections or lung disease.

9. Cancer & Immune Research

Thymalin has also appeared in research involving cancer and immune function. Researchers have investigated whether thymic peptide preparations can influence immune parameters in patients with malignancy or affect immune responses associated with cancer.

These studies should not be interpreted as evidence that Thymalin treats or cures cancer. Cancer treatment requires evidence from appropriately designed clinical trials, and Thymalin does not have an established oncology indication.

10. Haematopoietic Stem-Cell Research

More recent experimental work has investigated Thymalin in relation to human haematopoietic stem and progenitor cells. This research explores whether thymic peptide signalling may influence differentiation or immune-cell development.

This is mechanistically interesting because it connects thymic biology with the development of immune-cell populations. It remains an experimental research area rather than an established regenerative treatment.

11. Skin & Ageing Biology

Thymic peptide research has also extended into skin biology and age-related changes in the epidermis. Studies have investigated age-associated changes in thymic peptide-related activity in human skin.

These findings may help researchers understand links between systemic ageing, thymic biology and tissue ageing, but they do not establish Thymalin as a clinically proven anti-ageing or dermatological treatment.

12. Women & Female Biology

There is currently limited evidence specifically evaluating Thymalin in women’s health.

Most published research has not been designed specifically around menstrual-cycle biology, menopause, PMDD, PCOS, fertility or female-specific metabolic physiology. Any potential relevance to women currently comes mainly from general research into immune ageing, inflammation and neuroendocrine-immune biology.

There is therefore no established evidence that Thymalin treats a women-specific condition.

13. Thymalin vs Thymulin

Thymalin and thymulin are related but distinct. Thymulin is a specific thymic nonapeptide associated with zinc-dependent biological activity and has its own research literature. Thymalin refers to a thymic polypeptide preparation and should not be treated as simply another name for thymulin.

Some online peptide discussions blur these terms. Peps4Her keeps them separate because their composition, research history and evidence base are not interchangeable.

14. Human Clinical Evidence

Human research on thymic peptide preparations exists, including older studies investigating immune function, ageing, respiratory disease and other clinical settings. There are also more recent experimental studies involving Thymalin.

However, the overall evidence base has important limitations: many studies are older, sample sizes are often modest, formulations and study methods vary, and independent replication using contemporary international clinical-trial standards is limited.

Consequently, human research should be described as preliminary or historical rather than as proof of established clinical efficacy.

15. Safety & Pharmacology Research

Thymalin has a substantial historical research record, but that is not equivalent to the modern safety database available for approved medicines.

• Large contemporary randomised trials are limited
• Long-term safety data are limited
• Independent international replication is limited
• Standardised formulations and manufacturing specifications vary
• Reproductive and pregnancy-specific safety evidence is limited

The absence of extensive reported adverse-event data should therefore not be interpreted as proof of long-term safety.

What Does the Evidence Actually Show?

The strongest biological rationale for Thymalin is in thymic biology and immune regulation. Research has examined T-cell function, immunomodulation, immunosenescence, inflammation and neuroendocrine-immune signalling.

There is genuine human research, but much of it is older and geographically concentrated. Modern large-scale trials, independent replication and standardised clinical formulations remain important evidence gaps.

There is currently insufficient evidence to establish Thymalin as a proven longevity, anti-ageing, immune-boosting, anti-inflammatory, cancer or women-specific therapy.

The Peps4Her Takeaway

Thymalin is an investigational thymic peptide preparation with a long history of research into immune regulation and age-related immune biology.

Its most interesting research areas include T-cell biology, immunomodulation, immunosenescence, inflammation, neuroendocrine-immune signalling and experimental regenerative biology.

For women specifically, the research gap is substantial. There is no established indication for PMDD, menopause, PCOS, fertility, menstrual disorders or hormonal imbalance.

Peps4Her therefore presents Thymalin as an emerging research subject and separates biological plausibility and historical human research from demonstrated clinical efficacy.

Key Research

• Natural and synthetic thymic peptides as therapeutics for immune dysfunction — PubMed
• Thymulin and immunomodulation — PubMed
• Thymulin physiology and therapeutic potential — PubMed
• Thymus and the neuroendocrine-immune axis — PubMed
• Thymalin, epithalamin and longevity research — PubMed
• Thymalin and geroprotective research — PubMed
• Thymalin and human haematopoietic stem cells — PubMed
• Thymalin and gene-expression research in COVID-19 — PubMed
• Thymalin in COVID-19 treatment research — PubMed
• Thymus hormones and anti-inflammatory research — PubMed